Review



nrg1β1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems nrg1β1
    Evaluation of Rgs16 expression in acute and chronic injury and after <t>NRG1β1</t> stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.
    Nrg1β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 127 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+nrg1%CE%B21/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/pmc11983618-158-39-41
    Average 95 stars, based on 127 article reviews
    nrg1β1 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    1) Product Images from "Dynamic regulation of Rgs16 and its correlation with Neuregulin1 expression in acute and chronic nerve injury"

    Article Title: Dynamic regulation of Rgs16 and its correlation with Neuregulin1 expression in acute and chronic nerve injury

    Journal: Frontiers in Cell and Developmental Biology

    doi: 10.3389/fcell.2025.1540453

    Evaluation of Rgs16 expression in acute and chronic injury and after NRG1β1 stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.
    Figure Legend Snippet: Evaluation of Rgs16 expression in acute and chronic injury and after NRG1β1 stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.

    Techniques Used: Expressing, Quantitative Proteomics, Quantitative RT-PCR, Gene Expression, RNA Sequencing, Western Blot

    Related Articles

    Recombinant:

    Article Title: Recombinant Neuregulin 1 Does Not Activate Cardiomyocyte DNA Synthesis in Normal or Infarcted Adult Mice
    Article Snippet: .. Experimental mice were treated with recombinant human NRG1β1 (corresponding to the EGF domain, amino acid residues 176–256, #396-HB, R&D Systems, Minneapolis, MN), at a dose of 2.5 micrograms per mouse per IP injection, dissolved in saline containing 0.1% Bovine Serum Albumin (BSA); control mice received vehicle alone. ..

    Article Title: Nectin-like 4 Complexes with Choline Transporter-like Protein-1 and Regulates Schwann Cell Choline Homeostasis and Lipid Biogenesis in Vitro
    Article Snippet: Secondary antibodies are as follows: donkey anti-mouse Alexa 488 (Jackson ImmunoResearch, catalog no. 715-545-151, lot no. 125268); donkey anti-mouse rhodamine-X (Jackson ImmunoResearch, catalog no. 715-295-151, lot no. 126823); donkey anti-chicken Alexa 488 (Jackson ImmunoResearch, catalog no. 703-545-155, lot no. 125269); donkey anti-goat rhodamine-X (Jackson ImmunoResearch, catalog no. 705-295-147, lot no. 128297); goat anti-mouse Alexa 790 (light-chain specific; Jackson ImmunoResearch, catalog no. 115-655-174, lot no. 114402); donkey anti-rabbit Alexa 790 (Jackson ImmunoResearch, catalog no. 711-655-152, lot no. 125990); and donkey anti-chicken Alexa 790 (Jackson ImmunoResearch, catalog no. 703-655-155, lot no. 106150). .. Growth factors used are as follows: EGF domain of recombinant human NRG1β1 (EGF-D, R&D Systems 396-HB) and neural growth factor (NGF; AbD Serotec PMP04Z). .. Culture Media The media used are as follows: DMEM (Gibco 11995); neurobasal media (Gibco 21103); minimum Eagle's medium (Gibco 11090); Leibovitz's L-15 medium (Gibco 11415); fetal bovine serum (FBS; Gibco 16000); GlutaMax TM -I (Gibco 35050); forskolin (Sigma F6886); B27 supplement (Gibco 17504); glucose (Sigma G7528); cytosine-β-arabinofuranoside hydrochloride (Sigma C6645); fluorodeoxyuridine (Sigma F0503); uridine (Sigma U3750); Matrigel (growth factor reduced; Corning 354230);and poly- l -lysine (Sigma P4707).

    Injection:

    Article Title: Recombinant Neuregulin 1 Does Not Activate Cardiomyocyte DNA Synthesis in Normal or Infarcted Adult Mice
    Article Snippet: .. Experimental mice were treated with recombinant human NRG1β1 (corresponding to the EGF domain, amino acid residues 176–256, #396-HB, R&D Systems, Minneapolis, MN), at a dose of 2.5 micrograms per mouse per IP injection, dissolved in saline containing 0.1% Bovine Serum Albumin (BSA); control mice received vehicle alone. ..

    Saline:

    Article Title: Recombinant Neuregulin 1 Does Not Activate Cardiomyocyte DNA Synthesis in Normal or Infarcted Adult Mice
    Article Snippet: .. Experimental mice were treated with recombinant human NRG1β1 (corresponding to the EGF domain, amino acid residues 176–256, #396-HB, R&D Systems, Minneapolis, MN), at a dose of 2.5 micrograms per mouse per IP injection, dissolved in saline containing 0.1% Bovine Serum Albumin (BSA); control mice received vehicle alone. ..

    Control:

    Article Title: Recombinant Neuregulin 1 Does Not Activate Cardiomyocyte DNA Synthesis in Normal or Infarcted Adult Mice
    Article Snippet: .. Experimental mice were treated with recombinant human NRG1β1 (corresponding to the EGF domain, amino acid residues 176–256, #396-HB, R&D Systems, Minneapolis, MN), at a dose of 2.5 micrograms per mouse per IP injection, dissolved in saline containing 0.1% Bovine Serum Albumin (BSA); control mice received vehicle alone. ..



    Similar Products

    95
    R&D Systems nrg1β1
    Evaluation of Rgs16 expression in acute and chronic injury and after <t>NRG1β1</t> stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.
    Nrg1β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+nrg1%CE%B21/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/pmc11983618-158-39-41
    Average 95 stars, based on 1 article reviews
    nrg1β1 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    94
    R&D Systems serum nrg1β1 levels
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Serum Nrg1β1 Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+nrg1%CE%B21/Human+NRG1-beta+1%2FHRG1-beta+1+DuoSet+ELISA/pmc08957169-61-0-18
    Average 94 stars, based on 1 article reviews
    serum nrg1β1 levels - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant human nrg1β1 active domain
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Recombinant Human Nrg1β1 Active Domain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+nrg1%CE%B21/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/10__1161_slash_atvbaha__121__315957-53-0-18
    Average 95 stars, based on 1 article reviews
    recombinant human nrg1β1 active domain - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant human nrg1β1
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Recombinant Human Nrg1β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+nrg1%CE%B21/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/pmc08262096-161-0-7
    Average 95 stars, based on 1 article reviews
    recombinant human nrg1β1 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems nrg1β1 t176 k246
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Nrg1β1 T176 K246, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+nrg1%CE%B21/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/pmc07797946__mmc1-51-26-29
    Average 95 stars, based on 1 article reviews
    nrg1β1 t176 k246 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant nrg1β1
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Recombinant Nrg1β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+nrg1%CE%B21/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/pmc07349576-74-71-74
    Average 95 stars, based on 1 article reviews
    recombinant nrg1β1 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    Evaluation of Rgs16 expression in acute and chronic injury and after NRG1β1 stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Dynamic regulation of Rgs16 and its correlation with Neuregulin1 expression in acute and chronic nerve injury

    doi: 10.3389/fcell.2025.1540453

    Figure Lengend Snippet: Evaluation of Rgs16 expression in acute and chronic injury and after NRG1β1 stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.

    Article Snippet: Cells were centrifuged at 100 rcf for 5 min and then resuspended in a selective DMEM D-valine medium (AL251-500ML; HiMedia Laboratories, Thane, India) enriched with 10% FBS, 100 μg/mL streptomycin, 100 U/mL penicillin, 10 μM forskolin and 8 nM NRG1β1 (#396-HB, R&D Systems, Minneapolis, United States) and plated onto poly-L-lysine (PLL) coated culture dishes.

    Techniques: Expressing, Quantitative Proteomics, Quantitative RT-PCR, Gene Expression, RNA Sequencing, Western Blot

    NRG1β1 levels in the patient and control groups before and after antipsychotic drug treatment

    Journal: BMC Psychiatry

    Article Title: Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms

    doi: 10.1186/s12888-022-03856-9

    Figure Lengend Snippet: NRG1β1 levels in the patient and control groups before and after antipsychotic drug treatment

    Article Snippet: Serum NRG1β1 levels were tested using sandwich enzyme-linked immunosorbent assays (ELISAs) in accordance with the manufacturer’s instructions (DY377; R&D Systems, Minneapolis, MN, USA).

    Techniques: Control

    NRG1β1 levels in the responder and nonresponder groups before and after antipsychotic drug treatment

    Journal: BMC Psychiatry

    Article Title: Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms

    doi: 10.1186/s12888-022-03856-9

    Figure Lengend Snippet: NRG1β1 levels in the responder and nonresponder groups before and after antipsychotic drug treatment

    Article Snippet: Serum NRG1β1 levels were tested using sandwich enzyme-linked immunosorbent assays (ELISAs) in accordance with the manufacturer’s instructions (DY377; R&D Systems, Minneapolis, MN, USA).

    Techniques: